Global Regulatory Capacity

Global Regulatory Capacity

Paul Pomerantz, Worldwide Executive Director of the Drug Information Association, discusses the issues taxing regulatory agencies worldwide as well as clinical trial complexity, lack of global harmonization, regulatory workload and more.